XML 35 R18.htm IDEA: XBRL DOCUMENT
v3.25.4

GOODWILL | 12 Months Ended
--- | ---
Dec. 31, 2025
Goodwill and Intangible Assets Disclosure [Abstract] |
GOODWILL | NOTE 8 - GOODWILL The following table reflects the changes in the carrying amount of goodwill by reporting unit for the years ended December 31, 2025 and 2024:
| Healthcare |  | Industrial |  | Consolidated
(in thousands) | Gross Goodwill |  | Cumulative Impairments |  | Net Goodwill |  | Gross Goodwill |  | Cumulative Impairments |  | Net Goodwill |  | Gross Goodwill |  | Cumulative Impairments |  | Net Goodwill
Balance, December 31, 2023 | $ | 148,137 |  |  | $ | (32,055) |  |  | $ | 116,082 |  |  | $ | 322,137 |  |  | $ | (322,137) |  |  | $ | — |  |  | $ | 470,274 |  |  | $ | (354,192) |  |  | $ | 116,082 |
Impairment charge | — |  |  | (101,445) |  |  | (101,445) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (101,445) |  |  | (101,445) |
Foreign currency translation adjustments | 242 |  |  | — |  |  | 242 |  |  | — |  |  | — |  |  | — |  |  | 242 |  |  | — |  |  | 242 |
Balance, December 31, 2024 | $ | 148,379 |  |  | $ | (133,500) |  |  | $ | 14,879 |  |  | $ | 322,137 |  |  | $ | (322,137) |  |  | $ | — |  |  | $ | 470,516 |  |  | $ | (455,637) |  |  | $ | 14,879 |
Foreign currency translation adjustments | 696 |  |  | — |  |  | 696 |  |  | — |  |  | — |  |  | — |  |  | 696 |  |  | — |  |  | 696 |
Balance, December 31, 2025 | $ | 149,075 |  |  | $ | (133,500) |  |  | $ | 15,575 |  |  | $ | 322,137 |  |  | $ | (322,137) |  |  | $ | — |  |  | $ | 471,212 |  |  | $ | (455,637) |  |  | $ | 15,575 |
Interim and Annual Impairment Test During the Year Ended December 31, 2025 During the second quarter of 2025, management identified a triggering event for the Healthcare reporting unit resulting from macroeconomic uncertainties, updates to strategic plans and restructuring initiatives, and a decline in the Company's stock price. Accordingly, an interim goodwill impairment assessment was performed. Based on the results of the quantitative test, no impairment was identified, as the estimated fair value of the reporting unit exceeded its carrying value. We also tested our goodwill for impairment as of our annual impairment testing date, November 1, 2025, and no impairment was identified. Although no impairment was identified during the interim test and the annual test in 2025, future changes to operating results, cash flows, share price market capitalization, or discount rates could adversely affect the implied fair value of goodwill and may result in future impairment charges. Impairment of Goodwill During the Year Ended December 31, 2024 During the year ended December 31, 2024, as a result of the significant decline in the trading price of our common stock and our market capitalization as well as reduced long term cash flow forecasts, we performed an interim period quantitative goodwill impairment test as of September 30, 2024, and we recorded a $101.4 million goodwill impairment charge reported within Asset impairment charges on our consolidated statement of operations. Impairment of Goodwill During the Year Ended December 31, 2023 For the year ended December 31, 2023, we completed the required annual goodwill impairment test for each of our reporting units (Healthcare Solutions and Industrial Solutions) and we determined that the carrying value of our Industrial Solutions reporting unit exceeded its fair value by an amount that was in excess of the goodwill assigned to the Industrial Solutions reporting unit. We recognized a goodwill impairment charge of $279.8 million to write off the entire goodwill balance assigned to the Industrial Solutions reporting unit for the year ended December 31, 2023. This goodwill charge is reported within Asset impairment charges on our consolidated statement of operations.

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for goodwill. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 24 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482573/350-20-50-6 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482573/350-20-50-6 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482573/350-20-50-5 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482573/350-20-50-4 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 3A -Publisher FASB -URI https://asc.fasb.org/1943274/2147482573/350-20-50-3A Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482573/350-20-50-2 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/350-20/tableOfContent + Details
Name: | us-gaap_GoodwillDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration